All Medical Microbiology articles – Page 2
-
NewsNew study provides insight to why Covid vaccines hit some harder than others
Scientists have highlighted factors that may explain why some people perceived more side effects from the SARS-CoV2 vaccine than others, including stress, exercise, and use of hormonal birth control.
-
NewsInfections following hip replacement associated with an increased risk of death, study finds
Patients who develop a periprosthetic joint infection (PJI) after a total hip replacement have more than a five-fold increased risk of mortality within 10 years, according to new research.
-
NewsSevere COVID-19 can involve either exacerbated lung inflammation or high viral replication
Researchers report a study based on autopsies of 47 patients who died after being infected by the ancestral strain of SARS-CoV-2. The findings will support clinical decisions on the treatment of critical cases.
-
NewsScientists seek more effective treatment for under-the-radar STI
Researchers at Tulane University are leading a groundbreaking study to seek a more effective treatment for trichomoniasis, an infection that, despite being the most common curable sexually transmitted infection (STI) worldwide, continues to fly under the radar.
-
NewsWaging war on ‘superbugs’ in aged care
A new study explores the link between the widespread use of antibiotics in residential aged care and the resulting antibiotic resistant bacteria in the gut that can be passed on to other residents
-
NewsResearchers take inspiration from viruses to improve delivery of nucleic acid-based therapies to cancer cells
A researcher is developing a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells.
-
News Scientists discover superbug’s rapid path to antibiotic resistance
Researchers have discovered how a hospital superbug Clostridioides difficile (C.diff) can rapidly evolve resistance to vancomycin. In less than two months the bacteria could develop resistance to 32 times the initial antibiotic concentration.
-
NewsInnovations in cancer treatment through targeted bacterial vaccines
Scientists outline efforts to create an antibacterial vaccine capable of eliciting robust immune responses to selectively eradicate Fusobacterium nucleatum while preserving other microbiota.
-
NewsA human-centered AI tool to improve sepsis management
A proposed artificial intelligence tool to support clinician decision-making about hospital patients at risk for sepsis has an unusual feature: accounting for its lack of certainty and suggesting what data it needs to improve its predictive performance.
-
NewsNew technology ‘lights up’ bacteria in wounds for better infection prevention
Autofluorescence (AF) imaging uses violet light to illuminate molecules in the cell walls of any bacteria. Different types of bacteria turn different colors, allowing physicians to immediately determine how much and which types of bacteria are in the wound.
-
NewsPeople who recover from dengue are at higher risk of long-term health complications than those who recovered from COVID-19
People who caught dengue and recovered are more likely to face long-term health complications about a year later compared to those who contracted COVID-19, according to the findings of a Singapore-wide study.
-
NewsNIH grant establishes UAB’s Global Research Resource for Human Tuberculosis
A $5.8m grant led by Adrie Steyn, Ph.D., of the University of Alabama at Birmingham and the Africa Health Research Institute, or AHRI, in Durban, South Africa, will provide user-requested infected human lung tissue and analytical services to tuberculosis researchers worldwide.
-
NewsResearchers granted $5m to study antibiotic-resistant wound infections in Ukraine
A new project funded by the U.S. Department of Defense partners emergency medicine faculty with research clinicians in Ukraine to launch a research platform for studying war-related wound infections and inform future clinical trials.
-
NewsNew microbial fermentation manufacturing facility launched in Billingham
The UK’s life science sector has been bolstered by a £100m investment by FUJIFILM Diosynth Biotechnologies. This takes the form of a new microbial fermentation manufacturing facility in Billingham.
-
NewsScientists to investigate why men and women are hit by the flu differently
Turns out that there is a biological reason why women and men suffer viral infections like influenza differently – and a team of scientists are extending their research to better understand why and how to design better, possible sex-specific treatments.
-
NewsMulti-disciplinary team awarded $3.9 million to study mixed fungal-bacterial infections
A multi-disciplinary team was recently awarded $3.9 million from the National Institute of Allergy and Infectious Diseases for a project aimed at unravelling intricate mysteries surrounding complex fungal-bacterial infections.
-
NewsTrojan horse method gives malaria parasites a taste of their own medicine
Researchers have developed a trojan horse method that tricks malaria parasites into ingesting a fatal dose of drugs by exploiting the parasite’s need for cholesterol to survive.
-
NewsResearchers find promising new weapon against certain types of antibiotic-resistant bacteria
Researchers have discovered a new combination of substances that appears to combat a range of bacteria that causes conditions such as stomach ulcers and urinary tract infections, and that are increasingly developing antibiotic resistance.
-
NewsHospital awarded $12m to study best approach to treat mild pneumonia in young children
Ann & Robert H. Lurie Children’s Hospital of Chicago, in partnership with University of Utah Health, has been approved for $12 million in research funding for a study that will compare two ways to use antibiotics in young children with mild pneumonia.
-
NewsLargest study of its kind finds common lab tests aren’t reliable for diagnosing Long COVID
A new study found that most routine laboratory tests are not reliable for diagnosing Long Covid, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC).
